Previous studies using neutralizing antibodies to HMGB1 or its antagonists have indicated that extracellular HMGB1 is crucial for neuroinflammation and concomitant neuronal damages in animal models of neurological disorders and brain ischemia [8,9,10,11,12,13]. Here, HMGB1 is linked to brain ischemia.